An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Patient PositioningMonitoring, PhysiologicPressure Ulcer
Interventions
DEVICE

Zephyr BioPatch

"The ZephyrLIFE Hospital System includes the BioPatch™ device (consisting of the BioModule™ sensor, BioModule™ holder, and snap ECG electrodes), the ECHO radio system, and a software monitoring interface. The BioModule™ sensor is a Class II device, 510(k) cleared by the FDA, and commercially available.~The ZephyrLIFE Hospital System stores, transmits and displays vital sign data including ECG, HR, RR, body orientation, and activity to caregivers via a central station."

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY